Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo
- PMID: 21481498
- DOI: 10.1016/j.ejmech.2011.03.036
Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo
Abstract
We obtained 5 positive novel histone deacetylase inhibitors (HDACIs) from a polyoxometalate (POM) library by using a cell-based screening system targeting the p21 gene promoter. Among them, PAC-320, a new tri-organic-tin-substitute germanotungstate, displayed remarkable extracellular inhibitory activity. Meanwhile, the crystal structure of PAC-320 was characterized by X-ray crystallography. PAC-320 could stably exist under physiological conditions as revealed by UV spectrum, CV and TG. PAC-320 possessed a strong inhibitory effect to intracellular HDAC activity. More significantly, PAC-320 inhibited the growth of a variety of cancer cells, and exhibited remarkable anticancer effect in a hepatocarcinoma H22 cell mice model. This study revealed, for the first time, that the HDAC inhibitory activity is a mechanism by which POMs exert their anticancer effect.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity.Bioorg Med Chem Lett. 2010 Jul 1;20(13):3906-10. doi: 10.1016/j.bmcl.2010.05.020. Epub 2010 May 15. Bioorg Med Chem Lett. 2010. PMID: 20605448
-
Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.Bioorg Med Chem. 2012 Jun 15;20(12):3865-72. doi: 10.1016/j.bmc.2012.04.032. Epub 2012 Apr 21. Bioorg Med Chem. 2012. PMID: 22579621
-
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.Bioorg Med Chem. 2008 May 1;16(9):4839-53. doi: 10.1016/j.bmc.2008.03.050. Epub 2008 Mar 23. Bioorg Med Chem. 2008. PMID: 18397827
-
Identification of type-specific anticancer histone deacetylase inhibitors: road to success.Cancer Chemother Pharmacol. 2010 Sep;66(4):625-33. doi: 10.1007/s00280-010-1324-y. Epub 2010 Apr 17. Cancer Chemother Pharmacol. 2010. PMID: 20401613 Review.
-
Inside HDAC with HDAC inhibitors.Eur J Med Chem. 2010 Jun;45(6):2095-116. doi: 10.1016/j.ejmech.2010.02.030. Epub 2010 Feb 14. Eur J Med Chem. 2010. PMID: 20223566 Review.
Cited by
-
Ribosomal Protein L15 is involved in Colon Carcinogenesis.Int J Med Sci. 2019 Aug 6;16(8):1132-1141. doi: 10.7150/ijms.34386. eCollection 2019. Int J Med Sci. 2019. PMID: 31523176 Free PMC article.
-
The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.Oncotarget. 2017 Feb 21;8(8):13240-13252. doi: 10.18632/oncotarget.14658. Oncotarget. 2017. PMID: 28099941 Free PMC article.
-
Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.Angew Chem Int Ed Engl. 2019 Mar 4;58(10):2980-2999. doi: 10.1002/anie.201803868. Epub 2018 Oct 12. Angew Chem Int Ed Engl. 2019. PMID: 29893459 Free PMC article. Review.
-
Selective Targeting of Proteins by Hybrid Polyoxometalates: Interaction Between a Bis-Biotinylated Hybrid Conjugate and Avidin.Front Chem. 2018 Jul 11;6:278. doi: 10.3389/fchem.2018.00278. eCollection 2018. Front Chem. 2018. PMID: 30050897 Free PMC article.
-
A Novel Class I HDAC Inhibitor, AW01178, Inhibits Epithelial-Mesenchymal Transition and Metastasis of Breast Cancer.Int J Mol Sci. 2024 Jun 30;25(13):7234. doi: 10.3390/ijms25137234. Int J Mol Sci. 2024. PMID: 39000339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous